Company / R&D per Share
Jaguar Health, Inc. R&D per Share History
FY2015-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$56.16
FY2025
5-year range
$1.17 / $1205.89
FY2021-FY2025
Trend
-95.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D per Share has fluctuated over the past 9 years, ranging from $0.66 in FY2017 to $1205.89 in FY2024.
Based on SEC 10-K filings.
56.16 in FY2025 with a 10-year CAGR of +44.0%.
Improved from $25.29 to $56.16 over the past 3 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +30.5%
- 5-Year CAGR
- +116.8%
- 10-Year CAGR
- +44.0%
Key checks
Key Insights
- In FY2025, r&d per share decreased 95.3% year-over-year.
- Peak r&d per share was recorded in FY2024.
- Lowest r&d per share in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.49 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $56.16 | -95.3% |
| FY2024 | $1205.89 | +4667.5% |
| FY2022 | $25.29 | +2057.9% |
| FY2020 | $1.17 | -95.2% |
| FY2019 | $24.58 | +1567.0% |
| FY2018 | $1.47 | +124.0% |
| FY2017 | $0.66 | -17.4% |
| FY2016 | $0.80 | -45.7% |
| FY2015 | $1.47 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026